ROIV

Roivant Sciences Ltd. - Common Shares

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Venker EricPresident & Immunovant CEO
$49M1.6M shares
SellMay 22, 2026
$6.1M200k shares
$30.27
--
Venker EricPresident & Immunovant CEO
$7.0M1.8M shares
Grant / ExerciseMay 22, 2026
$770.0K200k shares
$3.85
--
Venker EricPresident & Immunovant CEO
$52M1.6M shares
Grant / ExerciseMay 20, 2026
$1.1M34.5k shares
$32.41
--
Pulik RichardCFO
$9.0M278.5k shares
Grant / ExerciseMay 20, 2026
$614.6K19k shares
$32.41
--
Pulik RichardCFO
$2.4M84k shares
Grant / ExerciseApr 20, 2026
$2.4M84k shares
$29.08
--
Venker EricPresident & Immunovant CEO
$49M1.6M shares
SellApr 20, 2026
$5.9M200k shares
$29.59
--

News

seekingalpha.comRoivant Sciences Ltd. (ROIV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 9seekingalpha.comRoivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 3seekingalpha.comRoivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcriptseekingalpha.comMay 29seekingalpha.comRoivant: Immunovant's Rheumatoid Arthritis Win Validates The Buyseekingalpha.comMay 21seekingalpha.comRoivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call Transcriptseekingalpha.comMay 20